We're sorry, but we couldn't find any results that match your search criteria. Please try again with different keywords or filters.
Loading
-
Starttime
-
Date
1:15 PM
-
- Oncology
Franciscan CKineta is a clinical-stage biotechnology company with a mission to develop next-generation immunotherapies that transform patients’ lives. Kineta has leveraged its expertise in innate immunity and is ... -
- Immunology
Franciscan BEYAM is a platform biotech company with strong animal efficacy data for an AI-informed self-amplifying RNA/DNA smart vector. We are seeking investment and strategic partnership opportunities. At Eyam, ... -
- CNS/Neurological
Franciscan DOYE is a clinical stage pharmaceutical company focused on a late stage, low risk 505(b)2 opportunity that has already achieved market adoption and uptake in the hospital market.
1:30 PM
-
- Infectious Diseases
Franciscan BProtalix is a commercial stage biopharmaceutical company focused on the development and commercialization of proprietary recombinant therapeutic proteins that target rare genetic diseases with unmet m ... -
- CNS/Neurological
Franciscan DPanorama Medicine is a world-leading drug developer in RNA splicing. Our AI-driven platform allows us to explore the vast, untapped RNA space for new modality discovery. We have built a pipeline with ... -
- Oncology
Franciscan CCompany Description: Cytovation is a clinical-stage immuno-oncology biotech focused on the development of CyPep-1, a first-in-class synthetic peptide that has been designed to selectively target cance ...
1:45 PM
-
- Infectious Diseases
Franciscan BCompany Description: Antisense Therapeutics Limited (ASX: ANP; OTC: ATHJY) is an Australian biotechnology company focused on rare diseases. Through a partnership with Ionis Pharmaceuticals (NASDAQ: IO ... -
- CNS/Neurological
Franciscan DCompany Description: Finding new therapies for brain diseases requires preclinical models and assays with increased clinical relevance. a:head aims to develop a human-based platform for generating com ... -
- Oncology
Franciscan CCompany Description: Yinuoke is a biotech company developing First-in-Concept therapies for cancer patients who have exhausted available therapies based on a deep and unique understanding of cancer bi ...
2:00 PM
-
- Oncology
Franciscan CCompany Description: Qualigen Therapeutics, Inc. (Nasdaq: QLGN), a clinical-stage therapeutics company focused on developing treatments for adult and pediatric cancers with potential for Orphan Drug D ... -
- CNS/Neurological
Franciscan DCompany Description: Jaya Biosciences (Jaya) is developing targeted gene therapies for impaired lysosome/autophagy function, a critical component in the etiology of severe neurodegenerative diseases, ... -
- Infectious Diseases
Franciscan BCompany Description: RS BioTherapeutics (RSBT) is developing a pharmaceutical compound for the treatment of Idiopathic Pulmonary Fibrosis (IPF) and other diseases characterized by pulmonary inflammati ...
2:15 PM
-
- Infectious Diseases
Franciscan BLactiga is an award-winning, visionary biotechnology company committed to pushing the boundaries of medical science and improving the lives of immunodeficient patients through innovative mucosal thera ... -
- Oncology
Franciscan CCompany Description: Welton Pharma is pre-clinical company developing our lead asset WP-038 for the treatment of colorectal cancer. Our patent-protected drug product is expected to increase the respon ... -
- CNS/Neurological
Franciscan DCompany Description: Ilios Therapeutics is a biopharmaceutical company discovering and developing rationally-designed multi-targeted therapeutics to combat neurodegenerative diseases. Our innovative c ...
2:30 PM
-
- Infectious Diseases
Franciscan BSarcomatrix is a preclinical stage biopharma developing novel therapeutics and enabling technologies across multiple indications; starting with muscle wasting diseases and muscular dystrophies. -
- CNS/Neurological
Franciscan DEpiVario Inc. is pioneering epigenetic therapeutic development to redefine treatment landscapes for neuropsychiatric disorders. Spun out of the Epigenetics Institute at the University of Pennsylvania, ... -
- Oncology
Franciscan CCompany Description: Amberstone Biosciences is developing a new class of paradigm-shifting, Tumor Microenvironment Activated ThErapeutic (“T-MATE”) antibodies and cytokines that can offer significantl ...
2:45 PM
-
- CNS/Neurological
Franciscan DClinical stage drug company engineering drug combinations to accelerate neuroplasticity (brain's capacity to rebuild, rewire, and repair). Target patients are those suffering brain injuries, deteriora ... -
- Oncology
Franciscan CCompany Description: VerImmune Inc (www.verimmune.com) is developing a highly innovative Virus-inspired Particle (ViP™) platform technology that has the potential to treat multiple diseases. VerImmune ... -
- Oncology
Franciscan BCompany Description: A multi-indication, radiosensitizing platform to increase the effectiveness of radiotherapy and immunotherapy.
3:00 PM
-
- Platform for Therapeutics
Franciscan DMacrobiome Therapeutics Pty Ltd is a company harnessing the therapeutic potential of hookworms and other parasitic helminths to develop drugs for the treatment of chronic wounds and autoimmune and met ... -
- Oncology
Franciscan CCompany Description: Kernal Bio is a biotech company developing mRNA 2.0 immunotherapies. Kernal mines translatome data to discover cell-specific sequence features and design mRNAs that are selectivel ... -
- Metabolic Diseases
Franciscan BCompany Description: Mitotech Ltd is a UK-based clinical stage biotechnology company developing mitochondria targeted drugs for a variety of neurodegenerative and metabolic diseases such as Obesity, N ...
3:15 PM
-
- Platform for Therapeutics
Franciscan DAlgen is a platform therapeutics and drug discovery company using the world’s leading CRISPR and AI to uncover disease-driving RNA messages to find treatments for cancer, inflammation and other diseas ... -
- Oncology
Franciscan CCompany Description: Degron Therapeutics is a preclinical-stage biotech dedicated to the discovery and development of a new class of targeted protein degradation therapeutics – small molecule molecula ... -
- Multiple Therapeutics
Franciscan BCompany Description: Sonata Therapeutics is creating a new class of therapeutics called network medicines. These are the first therapeutics designed specifically to reprogram diseased cells in order t ...
3:30 PM
-
- Oncology
Franciscan CCompany Description: Each year, an investment of $50 to $60 billion is directed towards oncology clinical trials, only to face an alarming 90% failure rate. The elevated failure rate largely stems fro ... -
- Platform for Therapeutics
Franciscan DCompany Description: Aperture Therapeutics is a pre-clinical stage drug discovery company developing novel therapeutics to modulate neuroinflammation in age-related neurodegenerative disorders. The co ... -
- Tools/Drug Development Support Tech
Franciscan BCompany Description: Synvivia optimizes cells for gene therapy manufacturing. Our technology increases gene therapy yield and potency by 3-10X, with thousands of improvements in the pipeline. Our prod ...
3:45 PM
-
- Oncology
Franciscan CPrivate pre-clinical Biotech developing novel small molecules for multiple solid tumors -
- Multiple Therapeutics
Franciscan BProven, clinical stage company discovering and developing first-in-class kinase inhibitors for diseases of the liver, kidney, and CNS. Lead program is phase 2-ready and will be evaluated in liver and/ ... -
- Platform for Therapeutics
Franciscan DCompany Description: Farcast's mission is to improve predictability in cancer treatment. Farcast's Human Tumor Microdynamics (hTMD) platform generates and mines“tumor response big data” by uniquely cu ...
4:00 PM
-
- Oncology
Franciscan CSynlico Inc. envisions rewriting medicine by bringing causality to cellular biology. As an AI-powered drug discovery biotech company, our primary mission is to develop cutting-edge engineered T cell t ... -
- Platform for Therapeutics
Franciscan DCompany Description: Kapoose Creek Bio is a Canadian biotech company using AI technologies to uncover small molecule medicines from nature with unprecedented speed and scale. Our R&D efforts are suppo ... -
- Multiple Therapeutics
Franciscan BCompany Description: Inimmune is harnessing the human immune system to create next generation immunotherapeutics for the treatment of allergy, infectious disease, autoimmunity, opioid addiction and ca ...
4:15 PM
-
- Platform for Therapeutics
Franciscan DCommercializing the human Trophoblast Stem Cell Platform for Cell and Gene Therapy -
- Oncology
Franciscan CCompany Description: YDS Pharmatech, Inc. is heading for next-generation induced-proximity drug discovery. Using our AI+biophysics simulation combined with proteomics technologies to advance the disco ... -
- Multiple Therapeutics
Franciscan BCompany Description: Caledon Bioscience is a newly formed, privately held, spin-out. We are a development stage biopharmaceutical company focused on discovering and developing novel and distinctive sm ...
)
)
){kind=logo}
){kind=logo}
){kind=logo}
)
){kind=logo}
)
)